These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 38672552)

  • 1. Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Olaoba OT; Yang M; Adelusi TI; Maidens T; Kimchi ET; Staveley-O'Carroll KF; Li G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.
    Joseph AM; Al Aiyan A; Al-Ramadi B; Singh SK; Kishore U
    Front Immunol; 2024; 15():1323198. PubMed ID: 38384463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
    Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components.
    Hsu SK; Jadhao M; Liao WT; Chang WT; Hung CT; Chiu CC
    Front Mol Biosci; 2022; 9():1020888. PubMed ID: 36299300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities.
    Myo Min KK; Ffrench CB; Jessup CF; Shepherdson M; Barreto SG; Bonder CS
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.
    Koikawa K; Kibe S; Suizu F; Sekino N; Kim N; Manz TD; Pinch BJ; Akshinthala D; Verma A; Gaglia G; Nezu Y; Ke S; Qiu C; Ohuchida K; Oda Y; Lee TH; Wegiel B; Clohessy JG; London N; Santagata S; Wulf GM; Hidalgo M; Muthuswamy SK; Nakamura M; Gray NS; Zhou XZ; Lu KP
    Cell; 2021 Sep; 184(18):4753-4771.e27. PubMed ID: 34388391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target.
    Hartupee C; Nagalo BM; Chabu CY; Tesfay MZ; Coleman-Barnett J; West JT; Moaven O
    Front Immunol; 2024; 15():1287459. PubMed ID: 38361931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Pancreatic Ductal Adenocarcinoma Treatment.
    Anderson EM; Thomassian S; Gong J; Hendifar A; Osipov A
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Tumor Microenvironment.
    Wang K; He H
    Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
    Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
    Qu C; Yuan H; Tian M; Zhang X; Xia P; Shi G; Hou R; Li J; Jiang H; Yang Z; Chen T; Li Z; Wang J; Yuan Y
    ACS Nano; 2024 Feb; 18(5):4019-4037. PubMed ID: 38253029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of pancreatic cancer therapy resistance by chemokines.
    Gautam SK; Basu S; Aithal A; Dwivedi NV; Gulati M; Jain M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):69-80. PubMed ID: 36064086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study.
    Kung HC; Yu J
    MedComm (2020); 2023 Apr; 4(2):e216. PubMed ID: 36814688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches.
    Truong LH; Pauklin S
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview.
    Panchal K; Sahoo RK; Gupta U; Chaurasiya A
    Int Immunopharmacol; 2021 Jun; 95():107508. PubMed ID: 33725635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma.
    Liu T; Chen Z; Chen W; Evans R; Xu J; Reeves ME; de Vera ME; Wang C
    Precis Clin Med; 2023 Mar; 6(1):pbad004. PubMed ID: 37007745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer.
    Guo J; Wang S; Gao Q
    Front Immunol; 2023; 14():1258538. PubMed ID: 37771596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma.
    Sato N; Cheng XB; Kohi S; Koga A; Hirata K
    Acta Pharm Sin B; 2016 Mar; 6(2):101-5. PubMed ID: 27006892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.
    Ahmad RS; Eubank TD; Lukomski S; Boone BA
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells associate with epithelial cells in the pancreatic ductal adenocarcinoma tumor microenvironment.
    Malchiodi ZX; Suter RK; Deshpande A; Peran I; Harris BT; Duttargi A; Chien MJ; Hariharan S; Wetherill L; Jablonski SA; Ho WJ; Fertig EJ; Weiner LM
    bioRxiv; 2024 May; ():. PubMed ID: 38853982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.